Literature DB >> 2109574

Successful single-dose prophylaxis of Staphylococcus aureus foreign body infections in guinea pigs by fleroxacin.

N Bouchenaki1, P E Vaudaux, E Huggler, F A Waldvogel, D P Lew.   

Abstract

Single-dose administration of fleroxacin was evaluated as a means of preventing foreign body infection due to staphylococci. Tissue cages were implanted into guinea pigs and subsequently infected (100% rate) with 10(2) or more CFU of Staphylococcus aureus Wood 46. When a single dose of 30 mg of fleroxacin or vancomycin per kg of body weight was administered intraperitoneally, bactericidal levels of the antimicrobial agent were found in the tissue cage fluid after 3 h (when guinea pigs were inoculated with S. aureus) and during the next 24 h. Either fleroxacin or vancomycin successfully prevented experimental infection in all tissue cages challenged by 10(2) CFU of S. aureus Wood 46. When tissue cages were challenged with 10(4) CFU of S. aureus Wood 46, however, fleroxacin was more effective than vancomycin (P less than 0.05) in reducing colony counts below the detection limit of 10 CFU/ml in the inflammatory fluid of all tissue cages during the initial 48 h. In contrast to their initially different actions, the effects of the antibiotics were similar after 7 days, mostly because bacterial regrowth occurred more frequently in the fleroxacin-treated than in the vancomycin-treated tissue cages. These data show that experimental infections of subcutaneous tissue cages are a useful model for studying the prophylaxis of foreign body infections with antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109574      PMCID: PMC171513          DOI: 10.1128/AAC.34.1.21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  The penetration of fleroxacin into intra-abdominal abscesses.

Authors:  D J Youngs; R G Tudor; K Yoshioka; M R Keighley
Journal:  J Antimicrob Chemother       Date:  1988-10       Impact factor: 5.790

2.  Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis.

Authors:  A G Gristina; J W Costerton
Journal:  J Bone Joint Surg Am       Date:  1985-02       Impact factor: 5.284

3.  Foreign body infection: role of fibronectin as a ligand for the adherence of Staphylococcus aureus.

Authors:  P Vaudaux; R Suzuki; F A Waldvogel; J J Morgenthaler; U E Nydegger
Journal:  J Infect Dis       Date:  1984-10       Impact factor: 5.226

4.  Pathogenesis of foreign body infection. Evidence for a local granulocyte defect.

Authors:  W Zimmerli; P D Lew; F A Waldvogel
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

5.  Pathogenesis of foreign body infection: description and characteristics of an animal model.

Authors:  W Zimmerli; F A Waldvogel; P Vaudaux; U E Nydegger
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

6.  Experimental hematogenous infection of subcutaneously implanted foreign bodies.

Authors:  W Zimmerli; O Zak; K Vosbeck
Journal:  Scand J Infect Dis       Date:  1985

7.  Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.

Authors:  M Fernandez-Guerrero; M Rouse; N Henry; W Wilson
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

8.  In-vitro susceptibility of staphylococci to fleroxacin in comparison with six other quinolones.

Authors:  D J Pohlod; L D Saravolatz; M M Somerville
Journal:  J Antimicrob Chemother       Date:  1988-10       Impact factor: 5.790

9.  Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers.

Authors:  M Nakashima; M Kanamaru; T Uematsu; A Takiguchi; A Mizuno; T Itaya; F Kawahara; T Ooie; S Saito; H Uchida
Journal:  J Antimicrob Chemother       Date:  1988-10       Impact factor: 5.790

10.  Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.

Authors:  M A Sande; R A Brooks-Fournier; J L Gerberding
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

View more
  11 in total

1.  Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections.

Authors:  A F Widmer; A Wiestner; R Frei; W Zimmerli
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

2.  Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.

Authors:  Pierre Vaudaux; Patrice Francois; Carmelo Bisognano; Jacques Schrenzel; Daniel P Lew
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infection.

Authors:  D S Kernodle; A B Kaiser
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

4.  Effect of treatment with methicillin and gentamicin in a new experimental mouse model of foreign body infection.

Authors:  F Espersen; N Frimodt-Møller; L Corneliussen; U Riber; V T Rosdahl; P Skinhøj
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

Review 5.  Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.

Authors:  J A Balfour; P A Todd; D H Peters
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

6.  Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.

Authors:  H J Schaad; C Chuard; P Vaudaux; F A Waldvogel; D P Lew
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

Review 7.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

8.  Lipid-based slow-release formulation of amikacin sulfate reduces foreign body-associated infections in mice.

Authors:  A A Roehrborn; J F Hansbrough; B Gualdoni; S Kim
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

9.  Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.

Authors:  A Cagni; C Chuard; P E Vaudaux; J Schrenzel; D P Lew
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

10.  Low prevalence of tissue detection of cefepime and daptomycin used as empirical treatment during revision for periprosthetic joint infections: results of a prospective multicenter study.

Authors:  O Robineau; E Talagrand-Reboulh; B Brunschweiler; F Jehl; E Beltrand; F Rousseau; N Blondiaux; A Grillon; C Joseph; P Lambotte; P Boyer; Eric Senneville
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-05-20       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.